Retinal Disorder clinical trials
18 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Stem Cell Ophthalmology Treatment Study II
- Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
- (CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000
- New Non-invasive Modalities for Assessing Retinal Structure and Function
- Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder
- Data Gathering for A10900
- Optimize Pediatric OCT Imaging
- Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
- Intraoperative OCT Guidance of Intraocular Surgery II
- DISCOVER Study: Microscope-integrated Intraoperative OCT Study
- National Eye Institute Biorepository for Retinal Diseases
- Cell Collection to Study Eye Diseases
- Advancing Pediatric Retinal Imaging With Auto-aligned OCT
- 4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800
- Visual Outcomes of Tecnis Symfony Opti-Blue EDOF Intraocular Lens (IOL)
- Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections
- Collecting Data on Retinal Blood Blood Flow and Blood Vessel Shape/Appearance Using an Investigational Device, XyCAM CRE, and to Then Compare Those Images With Images Collected From a Patient's Routine Clinical Examination.
- Retina BioBank: Retina Biomarkers for a Deeper Understanding of Vitreoretinal and Systemic Diseases
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Retinal Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.